Start Date
October 31, 2014
Primary Completion Date
May 31, 2015
Study Completion Date
Florbetapir (18F)
No Florbetapir (18F) will be administered in this study.
Research Site, Tokyo
Lead Sponsor
Avid Radiopharmaceuticals
INDUSTRY